Sequencing Analysis of SLX4/FANCP Gene in Italian Familial Breast Cancer Cases

Breast cancer can be caused by germline mutations in several genes that are responsible for different hereditary cancer syndromes. Some of the genes causing the Fanconi anemia (FA) syndrome, such as BRCA2, BRIP1, PALB2, and RAD51C, are associated with high or moderate risk of developing breast cance...

Full description

Bibliographic Details
Main Authors: Catucci, Irene, Colombo, Mara, Verderio, Paolo, Bernard, Loris, Ficarazzi, Filomena, Mariette, Frederique, Barile, Monica, Peissel, Bernard, Cattaneo, Elisa, Manoukian, Siranoush, Radice, Paolo, Peterlongo, Paolo
Format: Online
Language:English
Published: Public Library of Science 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3285620/
id pubmed-3285620
recordtype oai_dc
spelling pubmed-32856202012-03-01 Sequencing Analysis of SLX4/FANCP Gene in Italian Familial Breast Cancer Cases Catucci, Irene Colombo, Mara Verderio, Paolo Bernard, Loris Ficarazzi, Filomena Mariette, Frederique Barile, Monica Peissel, Bernard Cattaneo, Elisa Manoukian, Siranoush Radice, Paolo Peterlongo, Paolo Research Article Breast cancer can be caused by germline mutations in several genes that are responsible for different hereditary cancer syndromes. Some of the genes causing the Fanconi anemia (FA) syndrome, such as BRCA2, BRIP1, PALB2, and RAD51C, are associated with high or moderate risk of developing breast cancer. Very recently, SLX4 has been established as a new FA gene raising the question of its implication in breast cancer risk. This study aimed at answering this question sequencing the entire coding region of SLX4 in 526 familial breast cancer cases from Italy. We found 81 different germline variants and none of these were clearly pathogenic. The statistical power of our sample size allows concluding that in Italy the frequency of carriers of truncating mutations of SLX4 may not exceed 0.6%. Our results indicate that testing for SLX4 germline mutations is unlikely to be relevant for the identification of individuals at risk of breast cancer, at least in the Italian population. Public Library of Science 2012-02-23 /pmc/articles/PMC3285620/ /pubmed/22383991 http://dx.doi.org/10.1371/journal.pone.0031038 Text en Catucci et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Catucci, Irene
Colombo, Mara
Verderio, Paolo
Bernard, Loris
Ficarazzi, Filomena
Mariette, Frederique
Barile, Monica
Peissel, Bernard
Cattaneo, Elisa
Manoukian, Siranoush
Radice, Paolo
Peterlongo, Paolo
spellingShingle Catucci, Irene
Colombo, Mara
Verderio, Paolo
Bernard, Loris
Ficarazzi, Filomena
Mariette, Frederique
Barile, Monica
Peissel, Bernard
Cattaneo, Elisa
Manoukian, Siranoush
Radice, Paolo
Peterlongo, Paolo
Sequencing Analysis of SLX4/FANCP Gene in Italian Familial Breast Cancer Cases
author_facet Catucci, Irene
Colombo, Mara
Verderio, Paolo
Bernard, Loris
Ficarazzi, Filomena
Mariette, Frederique
Barile, Monica
Peissel, Bernard
Cattaneo, Elisa
Manoukian, Siranoush
Radice, Paolo
Peterlongo, Paolo
author_sort Catucci, Irene
title Sequencing Analysis of SLX4/FANCP Gene in Italian Familial Breast Cancer Cases
title_short Sequencing Analysis of SLX4/FANCP Gene in Italian Familial Breast Cancer Cases
title_full Sequencing Analysis of SLX4/FANCP Gene in Italian Familial Breast Cancer Cases
title_fullStr Sequencing Analysis of SLX4/FANCP Gene in Italian Familial Breast Cancer Cases
title_full_unstemmed Sequencing Analysis of SLX4/FANCP Gene in Italian Familial Breast Cancer Cases
title_sort sequencing analysis of slx4/fancp gene in italian familial breast cancer cases
description Breast cancer can be caused by germline mutations in several genes that are responsible for different hereditary cancer syndromes. Some of the genes causing the Fanconi anemia (FA) syndrome, such as BRCA2, BRIP1, PALB2, and RAD51C, are associated with high or moderate risk of developing breast cancer. Very recently, SLX4 has been established as a new FA gene raising the question of its implication in breast cancer risk. This study aimed at answering this question sequencing the entire coding region of SLX4 in 526 familial breast cancer cases from Italy. We found 81 different germline variants and none of these were clearly pathogenic. The statistical power of our sample size allows concluding that in Italy the frequency of carriers of truncating mutations of SLX4 may not exceed 0.6%. Our results indicate that testing for SLX4 germline mutations is unlikely to be relevant for the identification of individuals at risk of breast cancer, at least in the Italian population.
publisher Public Library of Science
publishDate 2012
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3285620/
_version_ 1611508063377817600